In BREAKWATER, EC plus FOLFIRI achieved a 64.4% response rate and showed a trend toward improved overall survival in patients ...

The only potentially curative options for gastric cancer involve endoscopic or surgical resection, with adjunctive systemic ...

Adding chemotherapy and bevacizumab to immunotherapy improves tumor control in a high-risk CRC subset, but this benefit comes ...

Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

I do not like to play doctor and self-medicate, but I read that some people have taken both medications together and have ...

Intermittent fasting is still very much in the research phase—but there are some promising findings. However, there's also ...

Young men increasingly feel the pressure to look jacked and they're going to extreme measures to achieve the aesthetic.

Artificial sweeteners, like aspartame and xylitol, offer sweetness without the calories of sugar. But are they actually ...

Ginger supplements can interact with other supplements and medications. Learn who should avoid other supplements with ginger.